References
AlHussaini, K.I. (2023) Microscopic Colitis: A Review Article. Cureus, 15, e47150. >https://doi.org/10.7759/cureus.47150
Hu, S., Zhao, R., Xu, Y., Gu, Z., Zhu, B. and Hu, J. (2024) Orally-Administered Nanomedicine Systems Targeting Colon Inflammation for the Treatment of Inflammatory Bowel Disease: Latest Advances. Journal of Materials Chemistry B, 12, 13-38. >https://doi.org/10.1039/d3tb02302h
Hung, T. H., Wang, C. Y. and Lee, H. F. (2023) Update in Diagnosis and Management of Irritable Bowel Syndrome. Tzu Chi Medical Journal, 35, 306-311. >https://doi.org/10.4103/tcmj.tcmj_104_23
Loveikyte, R., Bourgonje, A.R., van Goor, H., Dijkstra, G. and van der Meulen-de Jong, A.E. (2023) The Effect of Iron Therapy on Oxidative Stress and Intestinal Microbiota in Inflammatory Bowel Diseases: A Review on the Conundrum. Redox Biology, 68, Article ID: 102950. >https://doi.org/10.1016/j.redox.2023.102950
Schirmer, M., Garner, A., Vlamakis, H. and Xavier, R.J. (2019) Microbial Genes and Pathways in Inflammatory Bowel Disease. Nature Reviews Microbiology, 17, 497-511. >https://doi.org/10.1038/s41579-019-0213-6
Lloyd-Price, J., Arze, C., Ananthakrishnan, A.N., Schirmer, M., Avila-Pacheco, J., Poon, T.W., et al. (2019) Multi-Omics of the Gut Microbial Ecosystem in Inflammatory Bowel Diseases. Nature, 569, 655-662. >https://doi.org/10.1038/s41586-019-1237-9
Roy, S. and Dhaneshwar, S. (2023) Role of Prebiotics, Probiotics, and Synbiotics in Management of Inflammatory Bowel Disease: Current Perspectives. World Journal of Gastroenterology, 29, 2078-2100. >https://doi.org/10.3748/wjg.v29.i14.2078
Hidalgo-Cantabrana, C., Delgado, S., Ruiz, L., Ruas-Madiedo, P., Sánchez, B. and Margolles, A. (2017) Bifidobacteria and Their Health-Promoting Effects. Microbiology Spectrum, 5. >https://doi.org/10.1128/microbiolspec.bad-0010-2016
Li, M.Y., Luo, H.J., Wu, X., Liu, Y.H., Gan, Y.X., Xu, N., Zhang, Y.M., Zhang, S.H., Zhou, C.L., Su, Z.R., Huang, X.Q., and Zheng, X.B. (2020) Anti-Inflammatory Effects of Huangqin Decoction on Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice through Regulation of the Gut Microbiota and Suppression of the Ras-PI3K-Akt-HIF-1α and NF-κB Pathways. Frontiers in Pharmacology, 10, Article 1552. >https://doi.org/10.3389/fphar.2019.01552
Luo, S., Wen, R., Wang, Q., Zhao, Z., Nong, F., Fu, Y., Huang, S., Chen, J., Zhou, L. and Luo, X. (2019) Rhubarb Peony Decoction Ameliorates Ulcerative Colitis in Mice by Regulating Gut Microbiota to Restoring Th17/Treg Balance. Journal of Ethnopharmacology, 231, 39-49. >https://doi.org/10.1016/j.jep.2018.08.033
Yuan, Z., Yang, L., Zhang, X., Ji, P. and Wei, Y. (2020) Therapeutic Effect of N-Butanol Fraction of Huang-Lian-Jie-Du Decoction on Ulcerative Colitis and Its Regulation on Intestinal Flora in Colitis Mice. Biomedicine&Pharmacotherapy, 121, Article ID: 109638. >https://doi.org/10.1016/j.biopha.2019.109638
Liu, Y., Li, B.G., Su, Y.H., Zhao, R.X., Song, P., Li, H., Cui, X.H., Gao, H.M., Zhai, R.X., Fu, X.J. and Ren, X. (2022) Potential Activity of Traditional Chinese Medicine against Ulcerative Colitis: A Review. Journal of Ethnopharmacology, 289, Article ID: 115084. >https://doi.org/10.1016/j.jep.2022.115084
Zhang, B., Liu, K., Yang, H., Jin, Z., Ding, Q. and Zhao, L. (2022) Gut Microbiota: The Potential Key Target of TCM’s Therapeutic Effect of Treating Different Diseases Using the Same Method—UC and T2DM as Examples. Frontiers in Cellular and Infection Microbiology, 12, Article 855075. >https://doi.org/10.3389/fcimb.2022.855075
Nogales, C., Mamdouh, Z.M., List, M., Kiel, C., Casas, A.I. and Schmidt, H.H.H.W. (2022) Network Pharmacology: Curing Causal Mechanisms Instead of Treating Symptoms. Trends in Pharmacological Sciences, 43, 136-150. >https://doi.org/10.1016/j.tips.2021.11.004